Drug Treatment for Depressed Alcoholics (Naltrexone/Fluoxetine)
Status:
Completed
Trial end date:
2006-01-01
Target enrollment:
Participant gender:
Summary
This study will examine the effects of combing naltrexone and fluoxetine (Prozac) versus
fluoxetine and placebo in alcoholics with co-occurring major depression. Both groups will
actively participate in the 6-month study, which includes weekly individual Dual Disorders
Recovery Counseling during the first month and every two weeks during the second through
sixth months, plus the naltrexone and fluoxetine or fluoxetine and placebo. Subjects will
complete follow-up assessments at 9 and 12 months.
Phase:
Phase 4
Details
Lead Sponsor:
National Institute on Alcohol Abuse and Alcoholism (NIAAA)